← Back to Clinical Trials
Recruiting NCT07578987

NCT07578987 Effects of Kinetic Sand on Functional Reach and Eye-Hand Coordination in Children With Autism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07578987
Status Recruiting
Phase
Sponsor Riphah International University
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 17 participants
Start Date 2025-10-28
Primary Completion 2026-05-05

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Kinetic Sand Play

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 17 participants in total. It began in 2025-10-28 with a primary completion date of 2026-05-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A quasi-experimental pre-post study will be conducted at pediatric therapy clinics and special education centers, involving 17 children aged 6-12 years diagnosed with mild to moderate ASD, selected through convenient sampling. The intervention will consist of kinetic sand play for 30 minutes, three times per week, over six weeks, including activities such as molding objects, searching for hidden items, and free play to enhance creativity, grip strength, and coordination. Eye-hand coordination and functional reach will be assessed using the Purdue Pegboard Test (PPT) and the Functional Reach Test. Data will be analyzed using SPSS Version 26 with paired t-tests or appropriate non-parametric methods. Ethical approval will be obtained from the Research Ethical Committee of Riphah International University, Lahore.

Eligibility Criteria

Inclusion Criteria: * According to DSM-5 criteria, characterized by persistent deficits in social communication and interaction * Restricted, repetitive patterns of behavior or interests * Children demonstrating measurable impairments in functional reach and eye-hand coordination * Able to follow instructions Exclusion Criteria: * Children with severe intellectual disability, cerebral palsy, epilepsy or other neurological conditions that significantly impair motor function * Children currently receiving other intensive occupational or physical therapy targeting functional reach or eye-hand coordination * Presence of musculoskeletal deformities, severe visual impairments, or other medical conditions independently affecting motor skills or coordination

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 9233224390125

Principal Investigator

Huma Mumtaz, MS-PT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07578987 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07578987 currently recruiting?

Yes, NCT07578987 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07578987 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07578987 clinical trial?

NCT07578987 is sponsored by Riphah International University. The principal investigator is Huma Mumtaz, MS-PT at Riphah International University. The trial plans to enroll 17 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology